Session Details

[AL23]Daiichi Sankyo

Thu. Mar 27, 2025 11:05 AM - 11:45 AM JST
Thu. Mar 27, 2025 2:05 AM - 2:45 AM UTC
Room 2 (Fukuoka International Congress Center: 501 [5F])
Chair: Akio Ojida (Pharm., Kyushu Univ.)
[App translation available]

[AL23]Creation of trastuzumab deruxtecan, a novel cancer treatment drug, by innovating new-generation antibody-drug conjugate technology, DXd-ADC

Toshinori Agatsuma1, ○Yuki Abe1, Hiroyuki Naito1, Takashi Nakada1, Yusuke Ogitani1 (1. Daiichi Sankyo)